A New Biomarker in Alcohol Use Disorders: Carbohydrate Deficient Transferrin (CDT)
Keywords:
CDT, biomarker, alcohol abuse, diagnosis, alcohol screeningAbstract
Alcoholism is a serious disorder, which has a prevalence of %13.53 for men, %2.82 for women and %7.9 overall, was characterized by inability to resist desire for alcohol, excessive and frequent alcohol intake, which can disrupt individual’s physical and mental health and also family, work and social adaptation. Objective, sensitive, specific, reliable, economic, easily applicable biological markers are needed for diagnosis, treatment planning and prevention of relapse in alcoholism which can cause many alcohol related physical and mental disorders. Because of this, researchers are going on working for new biomarkers. Carbohydrate Deficient Transferrin (CDT) is new biomarker which is more specific and sensitive than traditional markers and approved by Food and Drug Administration (FDA). It was first reported by Stibler and Kjellin in 1976. Since than many researches were made on CDT and many articles were published on its usage in alcoholism. We investigated Pubmed data base by using key words alcohol, CDT, biomarker and transferrin in the literature published since 1976. And than we used the full text articles we managed to obtain to review literature on Carbohydrate Deficient Transferrin.
References
Standridge JB, Zylstra RG, Adams SM. Alcohol consumption. An overview of benefits and risks. South Med J 2004; 97: 664-672.
Mırsal H, Kalyoncu AÖ, Pektaş Ö. Alkol kullanımının biyokimyasal belirleyicileri ve klinik uygulamaları. Bağımlılık Dergisi 2002; 3: 165-172.
Ceylan ME, Türkcan A. Alkol ve Madde Kullanım Bozuklukları. Genişletilmiş 2. Baskı, İstanbul, 2003: 4-7.
Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol comsumption reviewed. Clin Chem 1991; 37: 2029-2037.
Bean P, De Bruin T, Harasymiv J, et al. New applications of contemperary biomarkers of alcohol consumption. Am Clin Lab 2002; 21: 1921.
Flahaut C, Michalski JC, Danel T, et al. A. The effects of ethanol on the glycosylation of human transferrin. Glycobiology 2003; 13: 191198.
Javors MA, Johnson BA. Current status carbohydrate-deficient transferrin, total serum sialic asid, serum sialic asid index of apolipoprotein J and serum beta-hexominidase as a markers for alcohol consumption. Addiction 2003; 98 (suppl 2): 45-50.
Helander A, Fors M, Zakrisson B. Study of Axis-shield new % CDT immunoassay for quantification of CDT in serum. Alcohol Alcohol 2001; 36: 406-412.
Viitalia K, Lasdesmaki K, Niemela O. Comparison of the Axis %CDT TIA and CDTect method as laboratory tests of alcohol abuse. Clin Chem 1998; 44: 1209-1215.
Van Pelt J, Leusink GL, Vannierop PW et al. Test caracteristics of CDT and GGT in alcohol using perimenopausal women. Alcohol Clin Exp Res 2000; 24: 176-179.
Helander A. Multicentre validation study of instrument applications for %CDT immunoassay for quantification carbohydrate-deficient transferrin in serum. Alcohol Alcohol 2002; 37: 209-212.
Pelt JV, Azimi H. False-positive values in patients with low ferritin values. Clin Chem 1998; 40: 2119-2120.
Helander A, Eriksson G, Stibler H, et al. Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem 2001; 47: 1225-1233.
Allen JP, Litten RZ, Anton RF, et al. Carbohydrate- deficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res 1994; 18: 799–812.
Bean P: Carbohydrate-Deficient Transferrin in the assessment of harmful alcohol consumption: diagnostic performance and clinical significance. Addict Biol 1999; 4: 151161.
Montalto NJ, Bean P. Use of contemporary biomarkers in the detection of chronic alcohol use. Med Sci Monit 2003; 9: 285-290.
Bell H, Tallaksen CME, Try K et al. Carbohydrate-deficient transferin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol Alcohol 1994; 18: 11031108.
Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 2001; 47: 13-27.
Anton RF, Moak DH: Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences. Alcohol Clin Exp Res 1994; 18: 747754.
Sillanaukee P, Olsson U. Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient transferrin and gammaglutamyltransferase. Clin Chem 2001; 47: 681685.
Mundle G, Ackermann K, Munkes J, et al. Influence of age, alcohol consumption and abstinence on the sensitivity of combining carbohydrate-deficient transferrin, gammaglutamyltransferase and mean corpuscular volume. Alcohol Alcohol 1999; 34: 760-766.
Conigrave KM, Davies P, Haber P, et al. Tradional markers of excessive alcohol use. Addiction 2003; 98 (suppl 2): 31-43.
Anton RF, Lieber C, Tabakoff B. Carbohydrate-deficient transferrin and gammaglutamyltransferase for the detection and monitoring of alcohol use: result from a Multisite study. Alcohol Clin Exp Res 2002; 26: 1215-1222.
Reynauld M, Schwan R, Loiseaux-Menuier MN, et al. Patients Admitted to emergency services for drunkenness: moderate alcohol users or harmful drinkers? Am J Psychiatry 2001; 158: 96-99.
Schmidt LG, Schmidt K, Dufeu P, et al. Superiority of carbohydrate-deficient transferrin to gammaglutamyltransferase in detecting relapse in alcoholism. Am J Psychiatry 1997; 154: 75-80.
Berlakovich GA, Windhager T, Freundorfer E et al. Carbohydrate-deficient transferin for detection of alcohol relapse after orthotopic liver transplantation for alcoholic cirrhosis. Transplantation 1999; 67: 1232-1235.
Mundle G, Ackerman K, Mann K. Biological markers as indicators for relapse in alcoholdependent patients. Addict Biol 1999; 4: 209214.
Limin S, Jarvis DR,Chick J, Simpson CD. Limitations of CDT and GGT in detecting relapses in patients attending an alcohol problem clinic. Scott Med J 1999; 44: 140-142.
Kverme AT, Buchmann M. Carbohydrate-deficient transferrin (CDT) and gamma-glutamyltransferase(GGT) in diagnosis and monitoring for abstinence among alcohol abusers. Hepatology 1997; 26 (4 Part 2): 544.
Mitchell C, Simpson D, Chick J. Carbohydrate-deficient transferrin in detecting relapse alcohol dependence. Drug Alcohol Depend 1997; 48: 97-103.
Allen JP, Sillanaukee P, AntonR. Contribution of carbohydrate-deficient transferrin to gammaglutamyltranspeptidase in evaluating progress of patients in treatment for alcoholism. Alcohol Clin Exp Res. 1999; 23: 115-120.
Romsan AS, Basu P, Galvin K, et al. Utility of carbohydrate-deficient transferin marker of relapse in alcoholic patients. Alcohol Clin Exp Res 1995; 19: 611-616
Kalyoncu A, Pektaş Ö, Mırsal H, Erdoğan G, Ünsalan N, Beyazyürek M. Erkek Alkol Bağımlılarında CDT düzeylerinin klinik verilerle ilişkisi. 40. Ulusal Psikiyatri kongresi özet kitabı. 2004: 628-630.
Türkcan A, Balkan R, Çakmak D. Alkol bağımlılığında CDT. 40. Ulusal Psikiyatri kongresi özet kitabı. 2004: 637-638.
Javors MA, Jhonson BA. Current status of carbohydrate deficint transferrin, total serum sialic asid, sialic asid index of apolipoprotein J and serum beta-hexaminidase as marker for alcohol consumption. Addiction 2003; 98 (Suppl 2): 45-50.
Wurst MF, Skipper GE, Weinmann W. Ethyl glucronide-the direct ethanol metabolite on the threshold from science to routine use. Addiction 2003; 98 (Suppl 2): 51-61.
Wurst FM, Alexson S, Wolfersdorf M et al. Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self reported-ethanol intake. Alcohol Alcohol 2004; 39: 33-38.
Harasymiw J, Bean P. The combined use of the early detection of alcohol consumption (EDAC) test and carbohydrate deficint transferrin to identify heavy drinking behaviour in males. Alcohol Alcohol 2001; 36: 349-353.
Harasymiw J, Vinson DC, Bean P. The EDAC score in the identification of heavy and at-risk drinkers from routine blood tests. J Addict Med 2000; 19: 43-59.
Harasymiw J, Bean P. Identification of heavy drinkers by using the early alcohol detection of alcohol consumption (EDAC) score. Alcohol Clin Exp Res 2001; 25: 228-235.
Hermanson U, Helander A,Brant L, et al. The alcohol use disorder identification test and CDT in Alcohol related sickness absense. Alcohol Clin Exp Res 2002; 26: 28-35.
Brathen G, Bjerve KS, Brodtkorb E,et al.Validity of CDT and other markers as diagnostic aids in the detection of alcohol related seizures. J Neurol Neurosurg Psychiatry 2000; 68: 342348.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Dependence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
...